The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus
Open Access
- 30 March 2006
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (4), 1283-1290
- https://doi.org/10.1002/art.21748
Abstract
Objective To determine the prevalence of lipid abnormalities at different times and to determine the influence of both the disease and corticosteroid therapy on lipid abnormalities in pediatric patients with systemic lupus erythematosus (SLE). Methods Lipid measurements were obtained in an inception cohort of 139 pediatric patients with SLE (114 females). Fasting levels of total cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol in the SLE patients were compared with those in age- and sex-matched control subjects. Disease activity levels and medication dosages were obtained at the time of lipid measurements. Results At the time of diagnosis, the mean levels of total cholesterol, LDL cholesterol, and triglycerides were highest, whereas the mean levels of HDL cholesterol were lowest. The percentage of patients with abnormal triglyceride values was highest at diagnosis, decreased at year 1, and then remained relatively constant thereafter. The mean total cholesterol and LDL cholesterol levels decreased at year 1 as compared with the time of diagnosis and then remained relatively constant. The lowest mean HDL cholesterol levels were found at the time of diagnosis, and these values rose with time. Comparison of lipid levels at different prednisone dosages and disease activity levels revealed that changes in triglyceride levels were mainly associated with changes in disease activity, changes in both total cholesterol and LDL cholesterol levels were associated with changes in the prednisone dosage and not disease activity, and low levels of HDL cholesterol were associated with active SLE, whereas the prednisone dosage was associated with increased levels of HDL cholesterol. Conclusion Factors intrinsic to SLE appear to alter lipid levels. Control of SLE may be the most important factor in improving abnormal lipid profiles, and paradoxically, prednisone therapy may improve abnormal lipid levels.Keywords
This publication has 41 references indexed in Scilit:
- Impact of multiple cardiovascular risk factors on femoral artery intima-media thickness in asymptomatic young adults (the Bogalusa Heart Study)The American Journal of Cardiology, 2005
- Framingham risk score is related to carotid artery intima-media thickness in both white and black young adults: the Bogalusa Heart StudyAtherosclerosis, 2003
- Cardiovascular risk factors and atherosclerosis in young males - ARMY study (atherosclerosis risk-factors in male youngsters)Cell Metabolism, 2003
- Serum Lipoprotein(a) Level and its Clinical Significance in Patients with Systemic Lupus ErythematosusClinical Rheumatology, 2002
- Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndromeKidney International, 2001
- Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosusArthritis & Rheumatism, 1999
- Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosusArthritis & Rheumatism, 1993
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- Acute myocardial infarction in pediatric systemic lupus erythematosusThe Journal of Pediatrics, 1990
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982